SANUWAVE Health (SNWV) Cash from Investing Activities (2010 - 2026)
SANUWAVE Health's (SNWV) quarterly Cash from Investing Activities came in at -$158000.0 in Q1 2026, up 2.47% year-on-year from -$154192.8 in Q1 2025, and down 156.63% on a QoQ basis from $279000.0 in Q4 2025.
SANUWAVE Health (SNWV) Cash from Investing Activities (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 15 years of Cash from Investing Activities data on file, last reported at -$158000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 2.47% year-over-year to -$158000.0 in Q1 2026; TTM through Mar 2026 was $3.4 million, a 738.85% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 800.61% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$158000.0, down from $279000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for SNWV reached as high as $4.5 million in Q3 2025 and fell as low as -$1.2 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged $184588.2 across 5 years, with a median of -$48000.0 in 2024.
- On a YoY basis, Cash from Investing Activities climbed as much as 9422.92% in 2025 and fell as far as 1159.78% in 2025.
- Year by year, Cash from Investing Activities stood at -$690000.0 in 2022, then jumped by 125.65% to $177000.0 in 2023, then slumped by 233.33% to -$236000.0 in 2024, then soared by 218.22% to $279000.0 in 2025, then plunged by 156.63% to -$158000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$158000.0 in Q1 2026, $279000.0 in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | SANUWAVE Health | 52.31 Mn | 41.53 Mn | 7.43 Mn | -158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -158,000.00 |
| Mar 31, 2026 | -158,000.00 |
| Dec 31, 2025 | 279,000.00 |
| Dec 31, 2025 | 279,000.00 |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | -162,000.00 |
| Mar 31, 2025 | -162,000.00 |
| Dec 31, 2024 | -236,000.00 |
| Dec 31, 2024 | -236,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -92,000.00 |
| Jun 30, 2024 | -92,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Dec 31, 2023 | 177,000.00 |